Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data
dc.contributor.author | Özkan, Meral | |
dc.date.accessioned | 2019-07-24T13:30:19Z | |
dc.date.available | 2019-07-24T13:30:19Z | |
dc.date.issued | 2018 | |
dc.department | İnönü Üniversitesi | en_US |
dc.identifier.citation | Özkan, M. (2018). Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data. Cilt:73, 46-46 ss. | en_US |
dc.identifier.endpage | 46 | en_US |
dc.identifier.startpage | 46 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/12915 | |
dc.identifier.volume | 73 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-elsevıer scıence ltd, the boulevard, langford lane, kıdlıngton, oxford ox5 1gb, england | en_US |
dc.relation.ispartof | Leukemıa research | en_US |
dc.rights | info:eu-repo/semantics/restrictedAccess | en_US |
dc.title | Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data | en_US |
dc.type | Article | en_US |
Dosyalar
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.71 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: